SB
Insider
Sangeeta N. Bhatia
DirectorSangeeta N. Bhatia (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $135K of VRTX (318 sh × $423.73, as filed), executed May 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$268K
shares × price, as filed
Last traded
May 4
Filed May 5
Median ADV $756.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $573K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
VRTX
Vertex Pharmaceuticals Incorporated
VRTX · 0 buys · 4 sells
4 filings
Recent filings
VRTXSALE
Vertex Pharmaceuticals Incorporated
View filing →
$135K318 sh × $423.73
Exec May 4
Filed May 5 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $133K
266 sh × $500.00
Exec Feb 13
Filed Feb 18 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $103K
266 sh × $386.69
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $202K
400 sh × $505.86
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET